tiprankstipranks
Apogee Therapeutics announces updated results from Phase 1 trial of APG777
PremiumThe FlyApogee Therapeutics announces updated results from Phase 1 trial of APG777
30d ago
Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer
Premium
The Fly
Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer
2M ago
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
3M ago
Apogee Therapeutics reports Q2 net loss $33.8M vs. $18.9M last year
PremiumThe FlyApogee Therapeutics reports Q2 net loss $33.8M vs. $18.9M last year
3M ago
NewAmsterdam Pharma appoints McKenna, Joustra to board of directors
Premium
The Fly
NewAmsterdam Pharma appoints McKenna, Joustra to board of directors
4M ago
Top Stock Gainers Today – LNTH, APGE, and More
Premium
Market News
Top Stock Gainers Today – LNTH, APGE, and More
5M ago
Apogee doses 1st patient in atopic dermatitis trial of IL-13 antibody APG777
PremiumThe FlyApogee doses 1st patient in atopic dermatitis trial of IL-13 antibody APG777
6M ago
Apogee expects cash to fund operations into Q1 of 2028
Premium
The Fly
Apogee expects cash to fund operations into Q1 of 2028
6M ago
Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
Premium
The Fly
Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100